Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/404"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"evidence_1520"
|
| rdf:type | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_type | |
| ?:content |
"The FDA lists this as a recommended in vivo substrate of CYP3A4 in it most recent guidance document. See Appendix A, Table 2, p. 19"
|
| dc:creator | |
| dc:date |
"05/21/2007 15:31:44"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ triazolam_primary_total_clearance_enzyme_cyp3a4, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1520 }